ANN ARBOR — Researchers have debated for more than two decades the likely impacts, if any, of global warming on the worldwide incidence of malaria, a mosquito-borne disease that infects more than 300 million people each year.
Now, University of Michigan ecologists and their colleagues are reporting the first hard evidence that malaria does—as had long been predicted—creep to higher elevations during warmer years and back down to lower altitudes when temperatures cool. (more…)
UCLA infectious diseases doctor played key role in finance strategy for therapy
A new international program, conceived in part by a UCLA physician, has rapidly transformed access to lifesaving anti-malarial drugs by providing cheap, subsidized artemisinin-based combination therapies in seven African countries that account for a quarter of the world’s malaria cases.
The first independent evaluation of the Affordable Medicines Facility–malaria (AMFm) program was recently published in the journal The Lancet. The program is based at the Global Fund in Geneva, an international financing institution dedicated to disbursing funds to prevent and treat infectious diseases. The evaluation shows that the program improved access to key artemisinin combination therapies, or ACTs, which offer broader protection and less antibiotic resistance than anti-malaria medications currently available in those African nations.(more…)
ANN ARBOR, Mich.—There are hundreds of millions of new cases of malaria annually, but much of what scientists believe about preventing the spread of malaria in urban settings is mistaken, a new University of Michigan study suggests.
